We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sanofi, AstraZeneca Agree to Share 210,000 Compounds for Development
Sanofi, AstraZeneca Agree to Share 210,000 Compounds for Development
Sanofi and AstraZeneca are touting an innovative, open model of collaboration that will see the direct exchange of 210,000 compounds between the two companies’ proprietary libraries.